• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pentoxifylline and complicated COVID-19: A pathophysiologically based treatment proposal.

作者信息

Assimakopoulos Stelios F, Seintis Fotios, Marangos Markos

机构信息

Department of Internal Medicine, Division of Infectious Diseases, University of Patras Medical School, Patras, Greece.

Department of Internal Medicine, Division of Infectious Diseases, University of Patras Medical School, Patras, Greece.

出版信息

Med Hypotheses. 2020 Oct;143:109926. doi: 10.1016/j.mehy.2020.109926. Epub 2020 May 30.

DOI:10.1016/j.mehy.2020.109926
PMID:32485316
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7260530/
Abstract
摘要

相似文献

1
Pentoxifylline and complicated COVID-19: A pathophysiologically based treatment proposal.己酮可可碱与复杂型新冠肺炎：基于病理生理学的治疗建议
Med Hypotheses. 2020 Oct;143:109926. doi: 10.1016/j.mehy.2020.109926. Epub 2020 May 30.
2
COVID-19 in hem/onc news.血液肿瘤新闻中的新冠病毒肺炎
Clin Adv Hematol Oncol. 2020 May;18(5):248.
3
COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET).新型冠状病毒肺炎与止血：来自意大利血栓形成与止血协会（SISET）的立场文件。
Blood Transfus. 2020 May;18(3):167-169. doi: 10.2450/2020.0083-20. Epub 2020 Apr 8.
4
Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report.托珠单抗，一种抗白细胞介素-6受体抗体，用于治疗新型冠状病毒肺炎相关呼吸衰竭：一例病例报告。
Ann Oncol. 2020 Jul;31(7):961-964. doi: 10.1016/j.annonc.2020.03.300. Epub 2020 Apr 2.
5
COVID-19 coagulopathy: an evolving story.新冠病毒感染相关凝血功能障碍：一个不断演变的故事。
Lancet Haematol. 2020 Jun;7(6):e425. doi: 10.1016/S2352-3026(20)30151-4.
6
Treating hypoxemic COVID-19 "ARDS" patients with almitrine: The earlier the better?用烯丙哌三嗪治疗低氧血症型新冠肺炎“急性呼吸窘迫综合征”患者：越早越好？
Anaesth Crit Care Pain Med. 2020 Aug;39(4):451-452. doi: 10.1016/j.accpm.2020.07.003. Epub 2020 Jul 9.
7
Interleukin-6 receptor antagonist therapy to treat SARS-CoV-2 driven inflammatory syndrome in a kidney transplant recipient.白细胞介素-6受体拮抗剂疗法治疗肾移植受者中由SARS-CoV-2驱动的炎症综合征。
Transpl Infect Dis. 2020 Aug;22(4):e13326. doi: 10.1111/tid.13326. Epub 2020 Jun 5.
8
Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia.精准皮质类固醇治疗对重症2019新型冠状病毒肺炎的潜在益处。
Signal Transduct Target Ther. 2020 Feb 21;5(1):18. doi: 10.1038/s41392-020-0127-9.
9
Severe Acute Kidney Injury in Patients with COVID-19 and Acute Respiratory Distress Syndrome.新型冠状病毒肺炎合并急性呼吸窘迫综合征患者的严重急性肾损伤
Am J Respir Crit Care Med. 2020 Nov 1;202(9):1299-1301. doi: 10.1164/rccm.202005-1524LE.
10
Successful treatment of severe COVID-19 with subcutaneous anakinra as a sole treatment.皮下注射阿那白滞素单一疗法成功治疗重症新型冠状病毒肺炎。
Rheumatology (Oxford). 2020 Aug 1;59(8):2171-2173. doi: 10.1093/rheumatology/keaa318.

引用本文的文献

1
The Role of Sequentially Monitored Laboratory Values and Inflammatory Biomarkers in Assessing the Severity of COVID-19.序贯监测实验室指标和炎症生物标志物在评估新型冠状病毒肺炎严重程度中的作用
Cureus. 2024 Jan 1;16(1):e51458. doi: 10.7759/cureus.51458. eCollection 2024 Jan.
2
SARS-CoV-2 Vaccination and Chilblain-like Lesions: What Do We Know so Far?新型冠状病毒2型疫苗接种与冻疮样病变：我们目前了解到了什么？
Dermatol Pract Concept. 2022 Oct 1;12(4):e2022170. doi: 10.5826/dpc.1204a170. eCollection 2022 Nov.
3
A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19.己酮可可碱在管理新冠病毒感染炎症性疾病中的应用前景。
Inflammopharmacology. 2022 Jun;30(3):799-809. doi: 10.1007/s10787-022-00993-1. Epub 2022 Apr 29.
4
Pentoxifylline-induced protein expression change in RAW 264.7 cells as determined by immunoprecipitation-based high performance liquid chromatography.基于免疫沉淀的高效液相色谱法测定 RAW 264.7 细胞中己酮可可碱诱导的蛋白质表达变化。
PLoS One. 2022 Mar 25;17(3):e0261797. doi: 10.1371/journal.pone.0261797. eCollection 2022.
5
Races of small molecule clinical trials for the treatment of COVID-19: An up-to-date comprehensive review.治疗 COVID-19 的小分子临床试验的种族差异：最新全面综述。
Drug Dev Res. 2022 Feb;83(1):16-54. doi: 10.1002/ddr.21895. Epub 2021 Nov 11.
6
Commonalities Between COVID-19 and Radiation Injury.新型冠状病毒肺炎与辐射损伤之间的共性
Radiat Res. 2021 Jan 1;195(1):1-24. doi: 10.1667/RADE-20-00188.1.